[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"coronary-ischemic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:coronary-ischemic":35},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,59,86],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":37,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100414271","icormica---stratified-medicine-in-angina-100414271",false,"NCT04674449","iCorMicA - Stratified Medicine in Angina","International Study of Coronary Microvascular Angina (iCorMicA): a Randomised, Controlled, Multicentre Trial and Registry","iCorMicA","Inclusion Criteria:\n\n1. Age ≥18 years.\n2. A clinical plan for invasive coronary angiography.\n3. Symptoms of angina (typical or atypical) according to the Rose- and\u002For Seattle Angina questionnaires.\n4. Able to comply with study procedures.\n5. Able to provide informed consent.\n\nExclusion Criteria:\n\n1. A non-coronary primary indication for invasive angiography (e.g. valve disease, heart failure).\n2. History of coronary artery bypass surgery.\n3. Presence of obstructive disease evident in a main coronary artery (diameter \\>2.5 mm), i.e. a coronary stenosis \\>50% and\u002For a fractional flow reserve (FFR) ≤0.80\\*.\n4. Logistical reason\\*. \\*These patients will enter a follow-up registry.","ALL","18 Years",{"count":20,"type":21},1500,"ESTIMATED","INTERVENTIONAL",[24],"NA","The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.",[27,28,29,30,31,32,33,34,35,36],"Microvascular Angina","Angina, Stable","Ischemia With No Obstructive Coronary Arteries (INOCA)","Coronary Microvascular Dysfunction (CMD)","Ischaemic Heart Disease","Non-Obstructive Coronary Atherosclerosis","Coronary Artery Disease","Vasospastic Angina","Coronary; Ischemic","Angina Attacks",[38,39,40,41,42,43,44,45],"angina","microvascular angina","ischaemia with no obstructive coronary artery disease (INOCA)","stratified medicine","clinical trial","outcomes research","prognosis","health economics","RECRUITING","2026-04-03",{"date":49,"type":50},"2026-04-09","ACTUAL",{"date":52,"type":50},"2020-12-30",{"date":54,"type":21},"2030-12-31",{"name":56,"class":57},"NHS Greater Glasgow and Clyde","OTHER",39,{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":11,"sex":17,"minAge":66,"maxAge":4,"enrollmentInfo":67,"targetDuration":4,"studyType":69,"phases":4,"briefSummary":70,"conditions":71,"keywords":72,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":85},"100506016","a-registry-of-cardiac-pet-and-cardioflux-magnetocardiography-in-patients-with-suspected-coronary-ischemia-100506016","NCT05868902","A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.","Magneto-PET","Inclusion Criteria:\n\n* Willing to provide informed consent\n* Male or female, aged 40 and up (inclusive) at the time of enrollment\n* Clinical suspicion of myocardial ischemia that clinician desired cardiac PET\n* Completed cardiac PET within 2 weeks prior to study enrollment\n\nExclusion Criteria:\n\n* Patients unable to fit into CardioFlux device.\n* Patients unable to lie supine for 5 minutes.\n* Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter\u002Fdefibrillators, infusion pumps, and\u002For neuro stimulators). NOTE: Sternotomy wires stents are acceptable\n* Ongoing atrial fibrillation or atrial flutter\n* Life expectancy \\\u003C1 yrs. due to non-cardiovascular comorbidity","40 Years",{"count":68,"type":21},300,"OBSERVATIONAL","A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.",[35],[73,74],"Magnetocardiography","Coronary Ischemia","2025-02-18",{"date":77,"type":50},"2025-02-20",{"date":79,"type":50},"2023-08-28",{"date":81,"type":21},"2025-12-31",{"name":83,"class":84},"Genetesis Inc.","INDUSTRY",2,{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":93,"targetDuration":95,"studyType":69,"phases":4,"briefSummary":96,"conditions":97,"keywords":99,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":110},"100426002","clinical-utility-and-outcome-prediction-of-cardiovascular-computed-tomography-predict-ct-100426002","NCT04827316","Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)","PREDICT-CT","Inclusion Criteria:\n\n* Adult individual \\>18 years\n* Undergoing clinically indicated CCTA\n* Signed informed consent or waiver\n\nExclusion Criteria:\n\n* None",{"count":94,"type":21},4200,"10 Years","In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.",[33,98,35],"Coronary Arteriosclerosis",[100],"Cardiovascular Computed Tomography","2024-10-16",{"date":103,"type":50},"2024-10-18",{"date":105,"type":50},"2017-06-01",{"date":107,"type":21},"2031-02-01",{"name":109,"class":57},"Insel Gruppe AG, University Hospital Bern",1]